KALV
KalVista Pharmaceuticals, Inc. · Healthcare
CEO Benjamin L Palleiko sold $193K of KalVista Pharmaceuticals, Inc.
Sold$193,066
$20.22Price
9,550Shares
−2%Stake
What KALV did after the filing
- The stock from Tue, Apr 21 open, $21.11
- +27.0%
- S&P 500, same days
- +5.7%
24 of 30 trading days so far, to the May 26 close.
Traded Fri, Apr 17. Filed Mon, Apr 20, 7:40 PM ET, after the close. Returns use the Apr 21 open and the May 26 close. Not investment advice.